Greene John has filed 6 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 4981 shares of NORTHROP GRUMMAN CORP /DE/ ($NOC) on February 11, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | NORTHROP GRUMMAN CORP /DE/ | $NOC | Greene John | CVP & Chief Financial Officer | A | Restricted Performance Stock Rights | 4981 | $0.00 | 4,981.0000 | 143,800,000 | 9999.99% | 0.00% |
| Feb. 11, 2026 | NORTHROP GRUMMAN CORP /DE/ | $NOC | Greene John | CVP & Chief Financial Officer | A | Restricted Stock Rights | 5362 | $0.00 | 5,362.0000 | 143,800,000 | 9999.99% | 0.00% |
| June 5, 2025 | CRISPR Therapeutics AG | $CRSP | Greene John | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| Feb. 26, 2025 | CRISPR Therapeutics AG | $CRSP | Greene John | Not found | P | Common Shares | 7000 | $44.85 | 7,000.0000 | 85,774,474 | 9999.99% | 0.01% |
| May 30, 2024 | CRISPR Therapeutics AG | $CRSP | Greene John | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | CRISPR Therapeutics AG | $CRSP | Greene John | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |